Song, K., Choi, M. J., Ghatak, K., Minh, N. N., Kwon, M., Ock, J., . . . Suh, J. (2018). AB083. TEW-7197, a novel orally bioavailable activin receptor-like kinase 5 inhibitor, promotes regression of fibrotic plaque in a rat model of Peyronie’s disease. Transl Androl Urol.
Chicago ZitierstilSong, Kang-Moon, Min Ji Choi, Kalyan Ghatak, Nguyen Nhat Minh, Mi-Hye Kwon, Jiyeon Ock, Guo Nan Yin, Ji-Kan Ryu, und Jun-Kyu Suh. "AB083. TEW-7197, a Novel Orally Bioavailable Activin Receptor-like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaque in a Rat Model of Peyronie’s Disease." Transl Androl Urol 2018.
MLA ZitierstilSong, Kang-Moon, et al. "AB083. TEW-7197, a Novel Orally Bioavailable Activin Receptor-like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaque in a Rat Model of Peyronie’s Disease." Transl Androl Urol 2018.